Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Patient Pathways 2026 - The Copay and Patient Services Congress
November 17-20, 2026
Sheraton Philadelphia DowntownPhiladelphia, PA

Amanda Masselam Strachan
Partner, WilmerHale at Former Chief, Criminal Division, U.S. Attorney's Office for the District of Massachusetts
Speaker

Profile

Amanda Masselam Strachan is a seasoned trial lawyer who advises clients in corporate investigations and litigation with an emphasis on white-collar defense and health care fraud enforcement. She leverages eighteen years as a federal prosecutor, including her roles as Chief of the Criminal Division and Chief of the Health Care Fraud Unit for the U.S. Attorney’s Office for the District of Massachusetts, to help clients navigate complex legal questions arising from the inquiries of federal and state prosecutorial authorities, regulators, and private litigants. Ms. Masselam Strachan has extensive experience conducting corporate investigations and trying complex cases. Prior to returning to private practice, she was a national leader in DOJ's efforts to combat fraud and abuse in the health care industry. She prosecuted and tried several high-profile health care fraud prosecutions, including the New England Compounding Center (NECC) cases, in which she convicted following multiple jury trials several individuals associated with the compounding pharmacy that caused the nationwide fungal meningitis outbreak. She handled several other landmark health care fraud cases, including the $650 million settlement with a management consulting firm for its work advising opioid manufacturers; the prosecution of Insys Therapeutics, Inc. for fraud and paying kickbacks through its speaker programs; and a $3 billion global plea and settlement with a pharmaceutical and biotechnology company relating to allegations of misbranding under the FDCA.

Agenda Sessions

  • Enforcement Update – DOJ Insights on Actions and Trends in the Copay and Patient Services Space

    10:45am

At this event